日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma

NRG Oncology/RTOG 9813 中的综合分子分析:间变性星形细胞瘤放射治疗联合替莫唑胺与放射治疗联合 BCNU/CCNU 的 III 期研究

Fleming, Jessica L; Pugh, Stephanie L; Chang, Susan M; McElroy, Joseph P; Becker, Aline P; Aldape, Kenneth D; Shih, Helen A; Ashby, Lynn Stuart; Hunter, Grant K; Bahary, Jean-Paul; Schultz, Christopher J; Kavanagh, Brian D; Puduvalli, Vinay K; Robins, H Ian; Werner-Wasik, Maria; Mehta, Minesh; Chakravarti, Arnab

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy

在线自适应高场磁共振引导放射治疗的安全性和耐受性

Westerhoff, Jasmijn M; Daamen, Lois A; Christodouleas, John P; Blezer, Erwin L A; Choudhury, Ananya; Westley, Rosalyne L; Erickson, Beth A; Fuller, Clifton D; Hafeez, Shaista; van der Heide, Uulke A; Intven, Martijn P W; Kirby, Anna M; Lalondrelle, Susan; Minsky, Bruce D; Mook, Stella; Nowee, Marlies E; Marijnen, Corrie A M; Orrling, Kristina M; Sahgal, Arjun; Schultz, Christopher J; Faivre-Finn, Corinne; Tersteeg, Robbert J H A; Tree, Alison C; Tseng, Chia-Lin; Schytte, Tine; Silk, Dustin M; Eggert, Dave; Luzzara, Marco; van der Voort van Zyp, Jochem R N; Verkooijen, Helena M; Hall, William A

Development of a multi-layer quality assurance program to evaluate the uncertainty of deformable dose accumulation in adaptive radiotherapy

开发多层质量保证程序,以评估自适应放射治疗中可变形剂量累积的不确定性

Zhong, Hualiang; Garcia-Alvarez, Juan A; Kainz, Kristofer; Tai, An; Ahunbay, Ergun; Erickson, Beth; Schultz, Christopher J; Li, X Allen

Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States

美国放射肿瘤科医师学术级别和薪酬的性别及种族/民族差异评估

Raldow, Ann C; Siker, Malika L; Bonner, James A; Chen, Yuhchyau; Liu, Fei-Fei; Metz, James M; Movsas, Benjamin; Potters, Louis; Schultz, Christopher J; Wilson, Emily; Wang, Xiaoyan; Romero, Tahmineh; Steinberg, Michael L; Jagsi, Reshma

Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry

MOMENTUM研究中首批接受新型高场磁共振直线加速器治疗的患者的治疗模式、耐受性和安全性:一项前瞻性多中心注册研究的初步结果

de Mol van Otterloo, Sophie R; Christodouleas, John P; Blezer, Erwin L A; Akhiat, Hafid; Brown, Kevin; Choudhury, Ananya; Eggert, Dave; Erickson, Beth A; Daamen, Lois A; Faivre-Finn, Corinne; Fuller, Clifton D; Goldwein, Joel; Hafeez, Shaista; Hall, Emma; Harrington, Kevin J; van der Heide, Uulke A; Huddart, Robert A; Intven, Martijn P W; Kirby, Anna M; Lalondrelle, Susan; McCann, Claire; Minsky, Bruce D; Mook, Stella; Nowee, Marlies E; Oelfke, Uwe; Orrling, Kristina; Philippens, Marielle E P; Sahgal, Arjun; Schultz, Christopher J; Tersteeg, Robbert J H A; Tijssen, Rob H N; Tree, Alison C; van Triest, Baukelien; Tseng, Chia-Lin; Hall, William A; Verkooijen, Helena M

The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer

年龄对局部晚期头颈癌放射治疗(XRT)+/-全身治疗的III期NRG Oncology/RTOG试验结果的影响

Kish, Julie A; Zhang, Qiang; Langer, Corey J; Nguyen-Tân, Phuc Felix; Rosenthal, David I; Weber, Randal S; List, Marcy A; Wong, Stuart J; Garden, Adam S; Hu, Kenneth; Trotti, Andy M; Bonner, James A; Jones, Christopher U; Yom, Sue S; Thorstad, Wade; Schultz, Christopher J; Ridge, John A; Shenouda, George; Harris, Jonathan; Le, Quynh-Thu

BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort

BRCA1蛋白表达可预测NRG肿瘤RTOG队列中胶质母细胞瘤患者的生存期

Vassilakopoulou, Maria; Won, Minhee; Curran, Walter J; Souhami, Luis; Prados, Michael D; Langer, Corey J; Rimm, David L; Hanna, Jason A; Neumeister, Veronique M; Melian, Edward; Diaz, Aidnag Z; Atkins, James N; Komarnicky, Lydia T; Schultz, Christopher J; Howard, Steven P; Zhang, Peixin; Dicker, Adam P; Knisely, Jonathan P S

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

NRG Oncology/RTOG 9802 中的综合基因组分析:一项针对高危低级别胶质瘤的 III 期临床试验,比较单纯放疗与放疗联合丙卡巴肼、洛莫司汀 (CCNU) 和长春新碱的疗效

Bell, Erica H; Zhang, Peixin; Shaw, Edward G; Buckner, Jan C; Barger, Geoffrey R; Bullard, Dennis E; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Stelzer, Keith J; McElroy, Joseph P; Fleming, Jessica L; Timmers, Cynthia D; Becker, Aline P; Salavaggione, Andrea L; Liu, Ziyan; Aldape, Kenneth; Brachman, David G; Gertler, Stanley Z; Murtha, Albert D; Schultz, Christopher J; Johnson, David; Laack, Nadia N; Hunter, Grant K; Crocker, Ian R; Won, Minhee; Chakravarti, Arnab

Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy

受体介导的 FIP200 聚集绕过了 LC3 脂化在自噬中的作用

Amelia E Ohnstad, Jose M Delgado, Brian J North, Isha Nasa, Arminja N Kettenbach, Sebastian W Schultz, Christopher J Shoemaker

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes

脉冲式低剂量率放射治疗联合贝伐单抗或单独使用贝伐单抗治疗复发性高级别胶质瘤:生存结果

Bovi, Joseph A; Prah, Melissa A; Retzlaff, Amber A; Schmainda, Kathleen M; Connelly, Jennifer M; Rand, Scott D; Marszalkowski, Cathy S; Mueller, Wade M; Siker, Malika L; Schultz, Christopher J